Kevin Patrick Danahy

Insider Reports History

Location
Braintree, MA
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Patrick Danahy:

Company Role Class Num Shares Value Price $ Report Date Ownership
PULSE BIOSCIENCES, INC. Chief Commercial Officer Common Stock 43,298 $802,311 $18.53 02 Oct 2025 Direct
PULSE BIOSCIENCES, INC. Chief Commercial Officer Stock Option (right to buy) 425,000 02 Oct 2025 Direct

Insider Reports Filed by Kevin Patrick Danahy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLSE PULSE BIOSCIENCES, INC. 02 Oct 2025 3 -$78,200 4 Chief Commercial Officer 07 Oct 2025, 19:18
PLSE PULSE BIOSCIENCES, INC. 18 Sep 2025 6 -$345,980 4 Chief Commercial Officer 22 Sep 2025, 21:24
PLSE PULSE BIOSCIENCES, INC. 03 Jul 2024 3 $0 4 Chief Commercial Officer 09 Jul 2024, 09:12
PLSE Pulse Biosciences, Inc. 16 Nov 2023 3 +$35,156 4 Chief Executive Officer 17 Nov 2023, 09:11
PLSE Pulse Biosciences, Inc. 23 Oct 2023 3 $0 4 Chief Executive Officer 03 Nov 2023, 17:41
PLSE Pulse Biosciences, Inc. 12 Jul 2023 1 $0 4 Chief Executive Officer 14 Jul 2023, 20:29
PLSE Pulse Biosciences, Inc. 29 Apr 2023 1 $0 4 Chief Executive Officer 02 May 2023, 21:45
PLSE Pulse Biosciences, Inc. 30 Sep 2022 1 +$14,950 4 Chief Executive Officer 03 Oct 2022, 16:35
PLSE Pulse Biosciences, Inc. 23 Sep 2022 1 $0 4 Chief Executive Officer 27 Sep 2022, 17:46
PLSE Pulse Biosciences, Inc. 17 Mar 2022 1 $0 4 Chief Executive Officer 24 Mar 2023, 16:31
PLSE Pulse Biosciences, Inc. 14 Feb 2022 1 $0 4 Chief Commercial Office 22 Mar 2022, 16:11
PLSE Pulse Biosciences, Inc. 14 Feb 2022 0 $0 3 Chief Commercial Officer 22 Mar 2022, 16:10